With pre‐treatment of NF‐κB inhibitors PDTC and TPCK, cell migration and VCAM‐1 were significantly abolished in CXCL13‐incubated lung cancer cells (Figure 6A‐C). This evidence concerns the gene NFKB1 and lung carcinoma.